InvestSMART

Telix Pharmaceuticals Limited (ASX:TLX)

ALERT: Price-sensitive ASX Announcement for TLX
Current share price for TLX : $17.180 2.42 (16.40%)+
Release
20 Apr 2026 4:47PM
Price at Release
$14.760
Full Release
download
Summary
Telix Pharmaceuticals Limited has successfully priced an upsized US$600 million convertible bond offering, reflecting strong investor interest. The company, which has refinanced its existing convertible bonds, will use the raised funds to support its strategic initiatives and growth. This announcement was managed by J.P. Morgan Securities plc.
Key Points
  • Telix Pharmaceuticals Limited announced successful pricing of an upsized convertible bond offering.
  • The offering totals US$600 million, reflecting strong investor interest.
  • The company refinanced existing convertible bonds.
  • Involved parties include J.P. Morgan Securities plc as the manager.
  • The funds will support Telix's strategic initiatives and growth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.